首页 › 基金 › SUPERSTRING CAPITAL MANAGEMENT LP › ROIV
SUPERSTRING CAPITAL MANAGEMENT LP 对 ROIV 的持仓历史
ROIVANT SCIENCES LTD · 医疗保健
SUPERSTRING CAPITAL MANAGEMENT LP 在 Q2 2026 的 13F 申报中披露持有 ROIV(ROIVANT SCIENCES LTD)25,623 股,市值约 US$907K,约占其申报组合的 0.57%,在其申报持仓中市值排名第 26 位。 SUPERSTRING CAPITAL MANAGEMENT LP 最近 11 个申报季度中有 3 个季度披露了 ROIV 持仓,最早可追溯至 Q4 2023。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
SUPERSTRING CAPITAL MANAGEMENT LP 对 ROIV 的持仓演变
SUPERSTRING CAPITAL MANAGEMENT LP 于 Q4 2023 首次披露 ROIV 持仓:326,161 股(约 US$3.7M)。 该持仓在 Q1 2024 达到峰值 531,019 股,市值约 US$5.6M。 在 3 次申报中,SUPERSTRING CAPITAL MANAGEMENT LP 1 次增持、0 次减持、0 次保持不变。 最近一期申报(Q2 2026)显示持股 25,623 股、市值约 US$907K。 持仓曾出现大幅变动:Q1 2024 增持约 63% (随后一个季度股价基本持平)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q4 2023 | 326.16K | $3.66M | 新进 |
| Q1 2024 | 531.02K | $5.60M | 增持 |
| Q2 2026 | 25.62K | $906.80K | 新进 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 ROIV 与 13F 数据
ROIV(ROIVANT SCIENCES LTD)属于医疗保健行业。我们追踪的基金中还有 64 只申报持有 ROIV,申报仓位最大的包括:QVT Financial LP (US$839.6M), 法拉龙资本管理 (US$506.4M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$506.4M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 ROIV 的基金
- QVT Financial LP 23.72M 股 · $839.56M · Q2 2026
- 法拉龙资本管理 14.31M 股 · $506.40M · Q2 2026
- FARALLON CAPITAL MANAGEMENT, L.L.C. 14.31M 股 · $506.40M · Q2 2026
- ADAGE CAPITAL PARTNERS GP, L.L.C. 10.35M 股 · $366.26M · Q2 2026
- PERCEPTIVE ADVISORS LLC 8.09M 股 · $286.14M · Q2 2026
- Patient Square Capital LP 8.02M 股 · $283.86M · Q2 2026
- Darwin Global Management, Ltd. 6.75M 股 · $234.33M · Q2 2026
- Rubric Capital Management LP 6.00M 股 · $212.34M · Q2 2026
- BAKER BROS. ADVISORS LP 4.72M 股 · $166.93M · Q2 2026
- Affinity Asset Advisors, LLC 3.75M 股 · $132.71M · Q2 2026
- ADAR1 Capital Management, LLC 3.16M 股 · $111.73M · Q2 2026
- Maverick 资本 2.83M 股 · $100.12M · Q2 2026
更多关于 SUPERSTRING CAPITAL MANAGEMENT LP
常见问题
How long has SUPERSTRING CAPITAL MANAGEMENT LP held ROIV?
SUPERSTRING CAPITAL MANAGEMENT LP has disclosed ROIV holdings in 3 of the last 11 reported quarters, going back to Q4 2023.
What is SUPERSTRING CAPITAL MANAGEMENT LP's current position in ROIV?
As of Q2 2026, SUPERSTRING CAPITAL MANAGEMENT LP holds 25.62K shares of ROIV (ROIVANT SCIENCES LTD), valued at $906.80K, representing 0.57% of its reported portfolio and ranking #26.
Has SUPERSTRING CAPITAL MANAGEMENT LP been buying or selling ROIV?
In the latest 13F filing (Q2 2026), SUPERSTRING CAPITAL MANAGEMENT LP newly opened its position in ROIV. The position peaked in Q1 2024 at 531.02K shares.
Which other funds hold ROIV?
Other major institutional holders of ROIV include QVT Financial LP, 法拉龙资本管理, FARALLON CAPITAL MANAGEMENT, L.L.C., among 64 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.